Navigation Links
Robbins & Myers Reports Record Third Quarter Results
Date:6/30/2008

Trailing Twelve Months Ended

May 31, May 31,

2008 2007

Net income $76,646 $40,813

Interest expense 2,656 6,972

Income taxes 44,286 28,127

Minority interest 2,339 1,128

EBIT 125,927 77,040

Minority interest (2,339) (1,128)

Depreciation & amortization $16,526 $16,902

EBITDA $140,114 $92,814

Special items:

(1) Process Solutions segment

Restructuring costs - (132)

Net product line/facility

sale gains - (5,036)

- (5,168)

(2) Romaco segment

Restructuring costs - 4,860

Net product line/facility

sale (gains)/losses (8,099) 19

(8,099) 4,879

Total Special Items (8,099) (289)

Adjusted EBIT $117,828 $76,751

Adjusted EBIT margin

Adjusted EBITDA $132,015 $92,525

Note: EBIT, adjusted EBIT, adjusted EBIT margin, and adjusted EBITDA are non-GAAP measures. We use these measures to evaluate our businesses, and we allocate resources to our busin
'/>"/>

SOURCE Robbins & Myers, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine news :

1. Robbins & Myers Schedules Third Quarter Fiscal 2008 Financial Results Conference Call
2. Robbins & Myers Reports Additional Gain and Increases Earnings Guidance
3. Robbins & Myers Schedules Second Quarter Fiscal 2008 Financial Results Conference Call
4. Robbins & Myers to Present at Gabelli Conference
5. Robbins & Myers to Present at Merrill Lynch Growth Industrials Conference December 13, 2007
6. Robbins & Myers Presenting at Bear Stearns 3rd Annual Commodities and Capital Goods Conference November 28, 2007
7. Robbins Bros. Gives Water at AIDS Walk L.A.
8. Robbins & Myers Announces Regular Quarterly Cash Dividend
9. Robbins & Myers to Release Fourth Quarter and 2007 Fiscal Year Results on Monday, October 15, 2007
10. Medarex and Bristol-Myers Squibb Joint Statement on Submission Status of Ipilimumab
11. Former Bristol-Myers Squibb Senior Vice President Indicted for Lying to the Federal Government About Popular Blood-Thinning Drug
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/3/2015)... First Choice Emergency Room , the ... United States, named Jeffrey Lynn Smaistrla, MD as the ... “We are pleased to announce Dr. Smaistrla is the ... Dr. James M. Muzzarelli, Executive Medical Director of First ... undergraduate and medical degrees from Texas A&M University. Dr. ...
(Date:3/3/2015)... 03, 2015 AliCare Medical Management ... management programs and a member of the Amalgamated ... Julie O’Brien as President. O’Brien formerly served as ... In her new role, she will continue with ... of AMM’s call center operations, including clinical services, ...
(Date:3/3/2015)... Aureus Medical Group (web: aureuslocumtenens.com), a national ... that it will participate as an exhibitor at the ... 2015 in St. Louis, MO. , CareerMD Career Fairs ... and fellows in a comfortable, relaxed setting. , Representatives ... available to speak with attendees about its full range ...
(Date:3/2/2015)... 02, 2015 Calvary Hospital recently ... Brooklyn Satellite in Lutheran Medical Center, with the ... must demonstrate excellence through clinical expertise as well ... to go above and beyond to make a ... patients and their families. Award recipients are chosen ...
(Date:3/2/2015)... (PRWEB) March 02, 2015 Cutler Integrative ... get to the root, gives cutting-edge tips to bring ... way to renew the body by first cleaning house. ... Naturopathic medicine, “We are all Toxic.” Between environmental toxins ... of potential greatness, and our high stress levels, we ...
Breaking Medicine News(10 mins):Health News:First Choice Emergency Room Announces Dr. Jeffrey Smaistrla as New Medical Director of LouettaFacility 2Health News:Julie O'Brien Named President of AliCare Medical Management 2Health News:Julie O'Brien Named President of AliCare Medical Management 3Health News:Calvary Hospital Honors Peter Acerios, RN, with Daisy Award 2Health News:Skin and Wellness Power Couple give Quick Tips to Self-Renewal for Spring 2
... , NASHVILLE, Tenn. , Jan. 12 Emdeon ... and payment cycle management solutions, today announced that it will make a ... be held from January 25 to 27, 2010 , in ... Chairman, will begin at 11:45 a.m. Eastern time on ...
... to stem smoking, while most states fell short , TUESDAY, ... important steps last year to prevent tobacco-related disease and death, ... alarming cuts to their tobacco control programs, a new report ... report, released Tuesday by the American Lung Association, the important ...
... , ... company that provides diet meal delivery services nationwide is announcing a new meal plan ... ... and delivery of delicious, perfectly-portioned meals, has launched a line of meals that can ...
... ... in Developing Countries , ... Trevose, PA (PRWEB) January 12, 2010 -- International SOS, ... customer care, has signed a memorandum of understanding with MediSend International to support ...
... In light of ... and reduce the risk of being exposed to this dangerous gas. , ... Charlotte, NC (PRWEB) January 12, 2010 - According ... the emergency room this year. The odorless, tasteless gas is created by most fuel-burning appliances ...
... ... infrastructure that is vendor interoperable will provide system-wide efficiency, patient safety benefits, and improve ... ... Nuvon, Inc., a provider of next generation BMDI (Biomedical Device Integration) solutions, and Virtua, ...
Cached Medicine News:Health News:Emdeon to Present at the Jefferies Global Healthcare Services Conference 2Health News:Report Card on Tobacco Control Laws a Mixed Bag 2Health News:Report Card on Tobacco Control Laws a Mixed Bag 3Health News:Report Card on Tobacco Control Laws a Mixed Bag 4Health News:Diet-to-Go Delivers Deliciously Healthy Vegetarian Meals 2Health News:International SOS and MediSend to Partner on Humanitarian Healthcare 2Health News:International SOS and MediSend to Partner on Humanitarian Healthcare 3Health News:Security Choice Warns Against Dangers of Carbon Monoxide 2Health News:Virtua Selects Nuvon, Inc. as its Device Connectivity and Integration Solution Provider 2Health News:Virtua Selects Nuvon, Inc. as its Device Connectivity and Integration Solution Provider 3
(Date:3/3/2015)... -- Although lung cancer is the third most prevalent ... drugs in the market for its treatment. Further, popular ... patent expiry in 2015 and 2017 respectively. As such, ... drug manufacturers are vying to tap into. Approximately 130 ... (SCLC) and non-small cell lung cancer (NSCLC) are in ...
(Date:3/3/2015)... ROCKVILLE, Md. , March 3, 2015  CASI ... company dedicated to the acquisition, development and commercialization of ... for the global market with a commercial focus on ... K. Ren , Ph.D., CASI,s Chief Executive Officer, will ... ROTH Conference, to be held March 8-11 in Dana ...
(Date:3/3/2015)... 2015  Soligenix, Inc. (OTCQB: SNGX) (Soligenix or ... that address unmet medical needs in the areas ... has received a positive recommendation from the Data ... company,s Phase 2 study evaluating SGX942, a first-in-class ... oral mucositis in patients undergoing chemoradiation (CRT) therapy ...
Breaking Medicine Technology:Targeted Lung Cancer Therapies Are Supplanting Conventional Treatments 2Targeted Lung Cancer Therapies Are Supplanting Conventional Treatments 3CASI Pharmaceuticals To Present At The 27th Annual ROTH Conference 2Soligenix Announces Positive Recommendation by Data Review Committee on its Phase 2 Clinical Trial of SGX942 for the Treatment of Oral Mucositis in Head and Neck Cancer Patients 2Soligenix Announces Positive Recommendation by Data Review Committee on its Phase 2 Clinical Trial of SGX942 for the Treatment of Oral Mucositis in Head and Neck Cancer Patients 3Soligenix Announces Positive Recommendation by Data Review Committee on its Phase 2 Clinical Trial of SGX942 for the Treatment of Oral Mucositis in Head and Neck Cancer Patients 4Soligenix Announces Positive Recommendation by Data Review Committee on its Phase 2 Clinical Trial of SGX942 for the Treatment of Oral Mucositis in Head and Neck Cancer Patients 5Soligenix Announces Positive Recommendation by Data Review Committee on its Phase 2 Clinical Trial of SGX942 for the Treatment of Oral Mucositis in Head and Neck Cancer Patients 6
... IRVINE, Calif.--(BUSINESS WIRE)--Apr 30, 2007 - Cobalis ... specializing in,anti-allergy medications, today announced it has ... that it would need,more time to combine ... single,database before un-blinding and conducting the statistical ...
... WIRE)--Apr 30, 2007 - Hemispherx Biopharma,Inc. (AMEX: ... of Immunology, April 2007) that explains the ... (Poly I : Poly C(12)U), a double-stranded ... Fatigue Syndrome and as an,adjuvant to other ...
Cached Medicine Technology:Cobalis Expects to Report Phase III Top-Line Results in May 2New Report Illuminates Ampligen's Unique Mechanism of Action 2New Report Illuminates Ampligen's Unique Mechanism of Action 3New Report Illuminates Ampligen's Unique Mechanism of Action 4
For the quantitative in vitro determination of Alkaline Phosphatase in serum or plasma....
... EMR,systems require you to,change the ... only,electronic patient charting,solution designed to ... around,five specific criteria to,enhance overall ... you to see,more patients in ...
... StatStrip point-of-care glucose monitor elevates bedside glucose ... performance that approaches the quality of central ... well glucose measuring strip technology. Current ... Novas exclusive Multi-Well system measures and corrects ...
... EMS provides service to companies in many ... stores and restaurants.There are no hidden charges at ... equipment and service are among the lowest in ... array of services ranging from MasterCard/Visa processing to ...
Medicine Products: